3-METHYL-1H-INDAZOLE-7-BORONIC ACID, 95.0%, 500mg

(2E)-1-(2-methoxyphenyl)-3-(thiophen-2-yl)prop-2-en-1-one, 95.0%, 2g

2-(1,3-Benzothiazol-2-yl)-1-phenylethan-1-one, 97%, 50mg

3-Cyclopentyloxy-benzaldehyde, 95.0%, 10g

4-Amino-2-bromobenzoic acid, 95.0%, 5g

Pipettes mélangeuses sans graduation, standard, 124 mm, 500 pièces

1,3,5-Trimethoxy-2-methylbenzene, 97%, 5g

1-Bromo-2,4-dichlorobenzene, 99.0%, 1g

4-{[4-(Trifluoromethyl)pyrimidin-2-yl]oxy}benzaldehyde, 95.0%, 5g

4-Bromo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 96%, 10g

(2-Chloro-6-(trifluoromethyl)pyridin-4-yl)boronic acid, 98%, 1g

{3-[(1-Benzyl-1H-indazol-3-yl)oxy]propyl}dimethylamine hydrochloride, 97.0%, 100mg

2-Chlorobenzo[d]thiazol-5-ol, 97%, 100mg